V. P. Demidov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
V. P. Demidov has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Tatiana Vladimirovna Gaponova
National Medical Research Center for Hematology
4 shared publications - Dmitriy S. Tikhomirov
National Medical Research Center for Hematology of the Ministry of Health of Russia
3 shared publications - Nikolay M. Kapranov
National Medical Research Center for Hematology, 125167 Moscow, Russia
3 shared publications - Tatiana A. Tupoleva
National Medical Research Center for Hematology of the Ministry of Health of Russia
3 shared publications - K. V. Shaidurova
National Medical Research Center for Hematology
2 shared publications - A. V. Bulgakov
National Medical Research Center for Hematology, Ministry of Health of Russia
1 shared publication
Latest Publications
- Open Access
- 7 November 2026
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 71 (3) , 347-355
Voluntary non-remunerated platelet donation as a benchmark of transfusion service maturity
Introduction . Platelet concentrate transfusion is an indispensable element of supportive care aimed at the prevention and treatment of haemorrhagic complications in patients with thrombocytopenia. Platelet concentrate is the most challenging blood component to procure, store and transport, while demand for it continues to grow. Aim : to characterize the patterns of voluntary non-remunerated platelet donation and to identify measures to improve the sustainability of platelet concentrate supply under high transfusion demand. Materials and Methods . A retrospective observational study covering the period from 04.01.2016 to 30.04.2026 was performed. National statistical data on platelet donation and clinical use of platelet concentrates, data on 18,422 donors of the National Medical Research Centre for Hematology who made 166,377 donations, and data on 874 patients who received 12,166 platelet concentrate units in 2025 were analyzed. Results . In Russia, the number of platelet donations increased by 108% in 2016–2025, while their share of all donations did not exceed 5 %. The share of voluntary non-remunerated platelet donations decreased from 45 % to 18 % in 2021–2025. At the Center, all platelet donations were voluntary and non-remunerated. Of 18,422 donors, 7,978 (43.3 %) made at least one plateletpheresis donation. 20.4 % of them, donors with 10 or more platelet donations (the “core”), provided 67.8 % of all platelet donations. The largest loss of donors occurred after the fi rst donation: 64% of donors returned for a second platelet donation, whereas at subsequent steps the probability of return was 78–93 %. As the number of donations increased, the median interval between donations decreased from approximately 150 to 25 days. Conclusion . The high volume of platelet concentrate procurement is sustained by more frequent donations from a limited group of regular donors (the “core”), while the total number of platelet donors is declining. Priorities for improving the sustainability of platelet procurement are increasing the proportion of donors who return for a second donation, retaining the core, and attracting regular donors of other blood components to platelet donation.
- 7 November 2026
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 71 (3) , 347-355
Open AccessVoluntary non-remunerated platelet donation as a benchmark of transfusion service maturity
Introduction . Platelet concentrate transfusion is an indispensable element of supportive care aimed at the prevention and treatment of haemorrhagic complications in patients with thrombocytopenia. Platelet concentrate is the most challenging blood component to procure, store and transport, while demand for it continues to grow. Aim : to characterize the patterns of voluntary non-remunerated platelet donation and to identify measures to improve the sustainability of platelet concentrate supply under high transfusion demand. Materials and Methods . A retrospective observational study covering the period from 04.01.2016 to 30.04.2026 was performed. National statistical data on platelet donation and clinical use of platelet concentrates, data on 18,422 donors of the National Medical Research Centre for Hematology who made 166,377 donations, and data on 874 patients who received 12,166 platelet concentrate units in 2025 were analyzed. Results . In Russia, the number of platelet donations increased by 108% in 2016–2025, while their share of all donations did not exceed 5 %. The share of voluntary non-remunerated platelet donations decreased from 45 % to 18 % in 2021–2025. At the Center, all platelet donations were voluntary and non-remunerated. Of 18,422 donors, 7,978 (43.3 %) made at least one plateletpheresis donation. 20.4 % of them, donors with 10 or more platelet donations (the “core”), provided 67.8 % of all platelet donations. The largest loss of donors occurred after the fi rst donation: 64% of donors returned for a second platelet donation, whereas at subsequent steps the probability of return was 78–93 %. As the number of donations increased, the median interval between donations decreased from approximately 150 to 25 days. Conclusion . The high volume of platelet concentrate procurement is sustained by more frequent donations from a limited group of regular donors (the “core”), while the total number of platelet donors is declining. Priorities for improving the sustainability of platelet procurement are increasing the proportion of donors who return for a second donation, retaining the core, and attracting regular donors of other blood components to platelet donation.
- Open Access
- 5 October 2025
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 70 (3) , 348-358
Blood borne infections in blood donors and the epidemiological situation in the Russian Federation
Introduction. The prevalence of blood-borne infections in the Russia remains high. Between 2016–2023, additional safety measures and requirements were introduced for the examination of donor blood, such as molecular screening for pathogens and additional HBV markers testing. Aim: to analyze the frequency of detection of blood-borne infections in blood donors against the background of the epidemiological situation in the Russian Federation. Materials and methods. Data from National Report (form No. 64) on the production, storage, transportation and clinical use of donor blood and data from the transfusion information system of the National Medical Research Center for Hematology, Russia, were used. Results. The implementation of new safety measures carried the risk of reducing the number of donors, but fortunately, this did not happen. By 2020, the prevalence of socially signifi cant infections among donors in the Russian Federation decreased from 18,064 cases to 5,596 cases. However, there was an increase in 2021. This trend correlates with the dynamics of morbidity rates among the population of the Russian Federation. The approach to the registration and control of blood-borne infections for donors differs from that of the general population. For example, HIV-vulnerable population groups are recommended only for voluntary testing, thus, the true incidence rate of HIV in Russia may exceed the offi cial data. A similar problem is observed with viral hepatitis. HBV markers were found in donors of blood and its components more often than other infectious markers. However, among the population of the Russian Federation, the incidence rate of HBV is lower than that of HIV infection (9 versus 40 cases per 100,000 population, respectively). Conclusion. The prevalence of blood-borne infections among the population of the Russian Federation creates a threat of infected people entering the donor population. Surveillance and control of viral hepatitis B and C requires improvement.
- 5 October 2025
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 70 (3) , 348-358
Open AccessBlood borne infections in blood donors and the epidemiological situation in the Russian Federation
Introduction. The prevalence of blood-borne infections in the Russia remains high. Between 2016–2023, additional safety measures and requirements were introduced for the examination of donor blood, such as molecular screening for pathogens and additional HBV markers testing. Aim: to analyze the frequency of detection of blood-borne infections in blood donors against the background of the epidemiological situation in the Russian Federation. Materials and methods. Data from National Report (form No. 64) on the production, storage, transportation and clinical use of donor blood and data from the transfusion information system of the National Medical Research Center for Hematology, Russia, were used. Results. The implementation of new safety measures carried the risk of reducing the number of donors, but fortunately, this did not happen. By 2020, the prevalence of socially signifi cant infections among donors in the Russian Federation decreased from 18,064 cases to 5,596 cases. However, there was an increase in 2021. This trend correlates with the dynamics of morbidity rates among the population of the Russian Federation. The approach to the registration and control of blood-borne infections for donors differs from that of the general population. For example, HIV-vulnerable population groups are recommended only for voluntary testing, thus, the true incidence rate of HIV in Russia may exceed the offi cial data. A similar problem is observed with viral hepatitis. HBV markers were found in donors of blood and its components more often than other infectious markers. However, among the population of the Russian Federation, the incidence rate of HBV is lower than that of HIV infection (9 versus 40 cases per 100,000 population, respectively). Conclusion. The prevalence of blood-borne infections among the population of the Russian Federation creates a threat of infected people entering the donor population. Surveillance and control of viral hepatitis B and C requires improvement.
- Open Access
- 16 November 2023
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 68 (3) , 382-389-389
Safety of plasma-derived blood products transfusions harvested from anti-SARS-CoV-2 positive and negative donors
Introduction. Testing for antibodies to the causative agent COVID-19 is not mandatory for donor blood or its components. It is unknown whether transfusion of plasma-containing blood components from seropositive donors is a safe procedure especially for immunocompromised hematological patients. Aim. To assess the frequency of adverse reactions and complications in hematological patients after transfusions of plasma-derived blood products harvested from anti-SARS-CoV-2 positive and negative donors. Material and Methods. 9152 transfusions of components harvested from anti-SARS-CoV-2 positive and negative donors were carried out from April 29, 2020 to January 21, 2022 at the NMRC for Hematology. Post-transfusion reactions and complications were analyzed in 576 hematological patients. 2059 plasma units, 327 cryosupernatant plasma units and 6766 cryoprecipitate doses were assessed. The occurrence of adverse reactions (hyperthermia) and complications within two hours after transfusion were evaluated. Results. Among 9152 blood units, anti-SARS-CoV-2 were detected in 2660 (29 %) cases and 6492 (71 %) were antibodies free. The analysis of adverse reactions and complications showed no significant differences in the incidence of adverse reactions in recipients after anti-SARS-CoV-2 positive and negative blood unit transfusions. Conclusion. There were no significant differences in the number of post-transfusion reactions when using donor blood components (fresh frozen plasma, cryosupernatant plasma, cryoprecipitate) obtained from donors in whose blood antibodies to SARS-CoV-2 were detected or not detected. Plasma-derived blood products from seropositive donors with a high degree of probability can be used to correct the plasma hemostasis path in hematological patients along with components prepared from seronegative donors.
- 16 November 2023
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 68 (3) , 382-389-389
Open AccessSafety of plasma-derived blood products transfusions harvested from anti-SARS-CoV-2 positive and negative donors
Introduction. Testing for antibodies to the causative agent COVID-19 is not mandatory for donor blood or its components. It is unknown whether transfusion of plasma-containing blood components from seropositive donors is a safe procedure especially for immunocompromised hematological patients. Aim. To assess the frequency of adverse reactions and complications in hematological patients after transfusions of plasma-derived blood products harvested from anti-SARS-CoV-2 positive and negative donors. Material and Methods. 9152 transfusions of components harvested from anti-SARS-CoV-2 positive and negative donors were carried out from April 29, 2020 to January 21, 2022 at the NMRC for Hematology. Post-transfusion reactions and complications were analyzed in 576 hematological patients. 2059 plasma units, 327 cryosupernatant plasma units and 6766 cryoprecipitate doses were assessed. The occurrence of adverse reactions (hyperthermia) and complications within two hours after transfusion were evaluated. Results. Among 9152 blood units, anti-SARS-CoV-2 were detected in 2660 (29 %) cases and 6492 (71 %) were antibodies free. The analysis of adverse reactions and complications showed no significant differences in the incidence of adverse reactions in recipients after anti-SARS-CoV-2 positive and negative blood unit transfusions. Conclusion. There were no significant differences in the number of post-transfusion reactions when using donor blood components (fresh frozen plasma, cryosupernatant plasma, cryoprecipitate) obtained from donors in whose blood antibodies to SARS-CoV-2 were detected or not detected. Plasma-derived blood products from seropositive donors with a high degree of probability can be used to correct the plasma hemostasis path in hematological patients along with components prepared from seronegative donors.
- Open Access
- 22 October 2022
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 67 (3) , 388-397-397
Characteristics and trends in the work of the Blood Service of the Russian Federation in 2016–2020
Introduction. Ensuring a sustainable supply of safe donor blood is crucial for strategic issues and challenges. The evaluation of donor characteristics as well as the volume of components harvested and issued to medical organizations in the Russian Federation is a topical task for the national blood service.Aim — to analyze the performance indicators of the national blood service for the procurement and provision of donated blood and its components to medical organizations from 2016–2020.Methods. Data on over 6.5 million donors who donated blood in Russia during 2016–2020 were analyzed. Data were obtained from Blood Service report form No. 39 “Blood products and derivatives”. Descriptive statistics were used during analysis.Results. A decrease of the number of blood donors per thousand population was shown (from 9.68 to 8.26, р < 0.0001). There was a decrease of the number of first-time donors and of the number of repeat donors (by 23 and 9.3 %, respectively) within studied period. Regular donor quantum increased from 71 to 76 %. The share of volunteer blood donors from 2016 to 2020 throughout the Russian Federation remained stable and amounted to 97.7–98.0 %. The total number of donations decreased by 6.0 % due to a significant decrease in the number of donations of automatic apheresis plasma (from 507,396 in 2016 to 388,742 in 2020, p < 0.001), at the same time, a significant increase in the number of donations platelets was noted (from 83,285 donations in 2016 to 126,574 in 2020, p < 0.001). During the follow-up period, there was an increase from 2.0 in 2016 to 2.21 in 2020 (10 %) in the average number of donations of blood components made by donors per year. Despite the decrease in the total number of donations in the analyzed period, the volume of blood components transferred for clinical use increased. The largest increase in blood components transferred at the request of medical organizations was noted for the concentrate of donor platelets (from 702,732 units in 2016 to 1,072,830 in 2020, by 34.5 %) and erythrocyte- containing blood components (from 491,791 liters in 2016 to 555,909 liters in 2020, by 13.5 %). A general trend was noted both towards a decrease in the frequency of detection of markers of bloodborne infections (from 16.8 to 7.7 %), and in individual infections. When analyzing the frequency of detection of infection markers, a significant difference was obtained in the group of newly registered and repeated donors (50,114 and 25,814, р < 0,001).Conclusion. The decrease of the number of cases of detection of infection markers and the redistribution of blood collection in accordance with the changing demands of medical organizations demonstrates a targeted strategy for improving the safety of transfusions, improving the quality of recruiting activities, and improving the principles of lean production of blood components.
- 22 October 2022
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 67 (3) , 388-397-397
Open AccessCharacteristics and trends in the work of the Blood Service of the Russian Federation in 2016–2020
Introduction. Ensuring a sustainable supply of safe donor blood is crucial for strategic issues and challenges. The evaluation of donor characteristics as well as the volume of components harvested and issued to medical organizations in the Russian Federation is a topical task for the national blood service.Aim — to analyze the performance indicators of the national blood service for the procurement and provision of donated blood and its components to medical organizations from 2016–2020.Methods. Data on over 6.5 million donors who donated blood in Russia during 2016–2020 were analyzed. Data were obtained from Blood Service report form No. 39 “Blood products and derivatives”. Descriptive statistics were used during analysis.Results. A decrease of the number of blood donors per thousand population was shown (from 9.68 to 8.26, р < 0.0001). There was a decrease of the number of first-time donors and of the number of repeat donors (by 23 and 9.3 %, respectively) within studied period. Regular donor quantum increased from 71 to 76 %. The share of volunteer blood donors from 2016 to 2020 throughout the Russian Federation remained stable and amounted to 97.7–98.0 %. The total number of donations decreased by 6.0 % due to a significant decrease in the number of donations of automatic apheresis plasma (from 507,396 in 2016 to 388,742 in 2020, p < 0.001), at the same time, a significant increase in the number of donations platelets was noted (from 83,285 donations in 2016 to 126,574 in 2020, p < 0.001). During the follow-up period, there was an increase from 2.0 in 2016 to 2.21 in 2020 (10 %) in the average number of donations of blood components made by donors per year. Despite the decrease in the total number of donations in the analyzed period, the volume of blood components transferred for clinical use increased. The largest increase in blood components transferred at the request of medical organizations was noted for the concentrate of donor platelets (from 702,732 units in 2016 to 1,072,830 in 2020, by 34.5 %) and erythrocyte- containing blood components (from 491,791 liters in 2016 to 555,909 liters in 2020, by 13.5 %). A general trend was noted both towards a decrease in the frequency of detection of markers of bloodborne infections (from 16.8 to 7.7 %), and in individual infections. When analyzing the frequency of detection of infection markers, a significant difference was obtained in the group of newly registered and repeated donors (50,114 and 25,814, р < 0,001).Conclusion. The decrease of the number of cases of detection of infection markers and the redistribution of blood collection in accordance with the changing demands of medical organizations demonstrates a targeted strategy for improving the safety of transfusions, improving the quality of recruiting activities, and improving the principles of lean production of blood components.